Changes in inflammatory markers after switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in virologically suppressed older people living with HIV

N. Funderburg, E. Bowman, A. Kettlehut,J. Gabriel, S. Navadeh, A. Weinberg,C. Blair,I. McNicholl,S. Chuck,R. Haubrich

ANTIVIRAL THERAPY(2020)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要